Boddepalli Amar Srikar and Mukthinuthalapati Mathrusri Annapurna*

GITAM Institute of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India

*Corresponding Author: Mukthinuthalapati Mathrusri Annapurna, GITAM Institute of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India.

Received: April 19, 2021; Published: May 20, 2021

Abstract

Etoricoxib is a non-steroidal anti-inflammatory drug which belongs to an oxicam class. It belongs to second-generation COX-2 inhibitors. Etoricoxib is insoluble in water and readily soluble in alkaline aqueous solutions. In the present paper the authors have reviewed the analytical methods already published till now in the literature for the estimation of Etoricoxib in pharmaceutical formulations and in biological samples.

Keywords: Etoricoxib; Fluids; Molecular Weight

References

1. Leclercq P and Malaise MG. “Etoricoxib (Arcoxia)”. Revue Medicale de Liege 5 (2004): 345-349.
2. Duncan MR and Capell HA. “Etoricoxib in the treatment of chronic pain”. International Journal of Clinical Practice4 (2003): 315-318.
3. Matsumoto AK., et al. “A randomized, controlled, clinical trial of Etoricoxib in the treatment of rheumatoid arthritis”. Journal of Rheumatology 29.8 (2002): 1623-1630.
4. Cochrane DJ., et al. “Etoricoxib Drugs”.18 (2002): 2637-2651.
5. Shahi SR., et al. “Development and validation of UV spectrophotometric method for the determination of Etoricoxib in bulk and tablet formulation”. Rasayan Journal of Chemistry2 (2008): 390-394.
6. Shipra Singh., et al. “A simple ultraviolet spectrophotometric method for the determination of Etoricoxib in dosage formulations”. Journal of Advanced Pharmaceutical Technology and Research 4 (2012): 237-240.
7. Juyal V., et al. “Development and validation of spectrophotometric method for estimation of Etoricoxib in tablet dosage forms”. Journal of pharmacy research2 (2009): 200-202.
8. Manish Kumar Thimmaraju., et al. “Determination of Etoricoxib in bulk and pharmaceutical dosage forms by UV spectrophotometric method”. International Journal of Pharm Tech Research2 (2012): 860-865.
9. Garlapati Manideep., et al. “Development and validation of a UV spectroscopic method to estimate Etoricoxib in bulk and tablet formulation”. Research Journal of Pharmacy and Technology2 (2018): 758-760.
10. Srinivasu Topalli., et al. “Validated RP- HPLC method for the assay of Etoricoxib (a non-steroidal anti-inflammatory drug) in pharmaceutical dosage forms”. E-Journal of Chemistry2 (2012): 832-838.
11. Manish Kumar Thimmaraju., et al. “RP HPLC method for the determination of Etoricoxib in bulk and pharmaceutical formulations”. Der Pharmacia Lettre5 (2011): 224-231.
12. Patel HM., et al. “Determination of Etoricoxib in pharmaceutical formulations by HPLC method”. Indian Journal of Pharmaceutical Sciences5 (2012): 703-705.
13. Gangane PS., et al. “Development and validation of HPLC assay method for Etoricoxib in bulk drug and tablet formulation”. Indian Journal of Natural Sciences24 (2014): 1565-1572.
14. Muhammad Alzweiri., et al. “Stability study of Etoricoxib a selectivecyclooxygenase-2 inhibitor by a new single and rapid reversed phase HPLC method”. Symmetry288 (2018): 1-12.
15. Ashok KS and Nooman AK. “High performance liquid chromatographic determination of Etoricoxib in human plasma”. Asian Journal of Chemistry7 (2007): 5241-5250.
16. Liberato Brum Junior., et al. “Validation of an LC‐Tandem MS/MS method for the determination of Etoricoxib in human plasma and pharmaceutical formulations”. Journal of Liquid Chromatography and Related Technologies1 (2006): 123-135.
17. Liberato Brum Junior., et al. “Determination of Etoricoxib in human plasma using automated on-line solid-phase extraction coupled with LC-APCI/MS/MS”. Quimica Nova3 (2008): 574-578.
18. Xiaoran Zhang., et al. “Rapid quantitative analysis of Etoricoxib in human plasma by UPLC‐MS/MS and application to a pharmacokinetic study in Chinese healthy volunteers”. Biomedical Chromatography2 (2019).
19. Gourab Maheshwari., et al. “High-performance thin-layer chromatographic determination of Etoricoxib in the bulk drug and in pharmaceutical dosage form”. Journal of Planar Chromatography 5 (2007): 335-339.
20. Maximiliano da Silva Sangoi., et al. “Validation of a capillary zone electrophoresis method for the comparative determination of Etoricoxib in pharmaceutical formulations”. Journal of Separation Science1 (2008): 169-176.

Citation

Citation: Boddepalli Amar Srikar and Mukthinuthalapati Mathrusri Annapurna. “A Review on the Analytical Techniques for the Quantification of Etoricoxib". Acta Scientific Pharmaceutical Sciences 5.6 (2020): 82-85.

Copyright

Copyright: © 2020 Boddepalli Amar Srikar and Mukthinuthalapati Mathrusri Annapurna. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.